QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026PRNewsWire · 4 days ago
Financial Analysis: Elutia (NASDAQ:ELUT) & QuidelOrtho (NASDAQ:QDEL)Defense World · Oct 18, 2026
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PRNewsWire · Oct 15, 2026
Reasons to Add QuidelOrtho Stock to Your Portfolio for NowZacks Investment Research · Oct 14, 2026
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWire · Oct 8, 2026
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsPRNewsWire · Oct 7, 2026QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.05 | $0.13 | Beat |
| May 5, 2026 | $0.37 | -$0.04 | Miss |
| Feb 11, 2026 | $0.43 | $0.46 | Beat |
| Nov 5, 2025 | $0.51 | $0.80 | Beat |
| Aug 5, 2025 | $0.00 | $0.12 | Beat |
| May 7, 2025 | $0.58 | $0.74 | Beat |